The Association of Serum Testosterone Levels With Recurrence andMortality After Acute Ischemic Stroke in Males

The current study aimed to investigate whether low testosterone predicted therecurrence and clinical outcomes after acute ischemic stroke (AIS) in males.From June 2015 through August 2017, the study prospectively enrolled 110 maleAIS patients. All received detailed evaluations at admission and were followedfor at least 1 year. The cumulative incidence, overall survival, length ofhospital stay, and the percentage of previous stroke were compared betweensubjects with testosterone 440 ng/dl. The median age was62 years (range, 35–93 years). The median serum testosterone at admission was438 [203] ng/dl (range, 44–816 ng/dl); 55 patients (50%) had testosterone